The Mirandola Biomedical District is today considered the world’s third largest hub in this sector and 90% of the provincial industry is concentrated here. The potential for development of companies in the biomedical district can be reinforced by their ability to use the results of institutional research and link their own competences with those of the university and health care system with the objective of identifying new paths of product and process innovation and generating new manufacturing units capable of placing on the market new products/services that are the fruits of research.